Skip to main content
Premium Trial:

Request an Annual Quote

LabCorp's FDA Warning Topped Most-Read GenomeWeb Daily News Articles Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb Daily News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Oct. 10.
 
1. FDA Warns LabCorp About 'Misbranded' OvaSure Test (from Oct. 8)
 
2. Sequenom Shares Fall on Potential Competition; Analyst Says Sell-off Is Unwarranted (from Oct. 7)
 
3. Stanford-Led Team Develops Sequencing-Based Maternal Blood Test for Fetal Chromosomal Abnormalities (from Oct. 7)
 
4. Wisconsin Launches Collaborative Genomics Research Project (from Oct. 10)
 
5. Invitrogen Sues Oxford Biomedical, Vanderbilt Over Patent Licensing Deal (from Oct. 9)
The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.